Help Shape the Future of Warm Autoimmune Hemolytic Anemia Research
Learn more about the warm autoimmune hemolytic anemia (wAIHA) SApHiAre clinical study and how you or a loved one can participate.
![](https://cdn.prod.website-files.com/65566153ead73178a96dc2ba/65858e155ce530f81742229b_Screenshot%202023-12-22%20at%208.24.11%20AM.png)
Learn more about the warm autoimmune hemolytic anemia (wAIHA) SApHiAre clinical study and how you or a loved one can participate.
This is a research study for adults with warm autoimmune hemolytic anemia (wAIHA).
The purpose of this study is to learn if a new investigational drug call obexelimab
[ah-bex-El-ih-mab] can safely help improve anemia caused by wAIHA.
The study will include approximately 134 participants worldwide. You may be able to join the study if you:
The study drug (obexelimab or placebo) is given as an injection under the skin every
7 days. At first you will receive the injection at the study clinic. Then, you or a caregiver may be trained to give the injection at home, or you can continue to come to the study clinic for the injection.
Contact us to find out more: